ImmuneXcite Secures $2,418,788 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a3e0123-a943-4794-979a-ac243e3a532e&Preview=1 -
Date
1/5/2012 -
Company Name
ImmuneXcite -
Mailing Address
64 Grove Street Watertown, MA 02472 -
Company Description
ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets. -
Website
http://www.immunexcite.com -
Transaction Type
Venture Equity -
Transaction Amount
$2,418,788 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
